| Imac Regeneration Center | |
|
2725 James Sanders Blvd, Suite A, Paducah, KY 42001-8401 | |
| (270) 554-5114 | |
| (270) 554-5021 |
| Full Name | Imac Regeneration Center |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner |
| Location | 2725 James Sanders Blvd, Paducah, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083727994 | NPI | - | NPPES |
| Provider Name | Erica Young |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710185517 PECOS PAC ID: 6507803103 Enrollment ID: I20050414001037 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Matthew C Wallis |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1851499388 PECOS PAC ID: 5890719785 Enrollment ID: I20060118000697 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Robert A Garneau |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1962498113 PECOS PAC ID: 2668370339 Enrollment ID: I20081111000361 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Derek W Snodgrass |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1992971600 PECOS PAC ID: 8628141140 Enrollment ID: I20090707000036 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Matthew B Tackett |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1588721757 PECOS PAC ID: 4082649215 Enrollment ID: I20091013000028 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Donald R Douglas |
|---|---|
| Provider Type | Practitioner - Pain Management |
| Provider Identifiers | NPI Number: 1053416313 PECOS PAC ID: 5395934103 Enrollment ID: I20110110000745 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Tommy G West |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1093747040 PECOS PAC ID: 0244251536 Enrollment ID: I20111123000210 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Daniel Richard Farr |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1316044068 PECOS PAC ID: 2466548128 Enrollment ID: I20120222000174 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Mary Elisabeth Chase |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1962779801 PECOS PAC ID: 3779744040 Enrollment ID: I20120412000604 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Heidi R Schweder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043609183 PECOS PAC ID: 8820315393 Enrollment ID: I20150320001147 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Daniel Jennewein |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1851780613 PECOS PAC ID: 9234411323 Enrollment ID: I20170125002206 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Rachel Rome |
|---|---|
| Provider Type | Practitioner - Interventional Radiology |
| Provider Identifiers | NPI Number: 1679795256 PECOS PAC ID: 6608065552 Enrollment ID: I20170202000229 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Leslye Bransford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194269464 PECOS PAC ID: 7911280995 Enrollment ID: I20170217000893 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Aaron Wayne Colson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396987244 PECOS PAC ID: 6406194695 Enrollment ID: I20190213002749 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Matthew D Walters |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124335245 PECOS PAC ID: 3274712450 Enrollment ID: I20191125001721 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Tyler F Ward |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760026371 PECOS PAC ID: 0345673828 Enrollment ID: I20191216000403 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Kayla Hendley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326685066 PECOS PAC ID: 1052745874 Enrollment ID: I20200102000731 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Douglas Bouldin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770568727 PECOS PAC ID: 4880693936 Enrollment ID: I20200227000541 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Mercedes Robinson |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1285163139 PECOS PAC ID: 1658793450 Enrollment ID: I20200624002397 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Brittany Danielle Massey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528676178 PECOS PAC ID: 8325462195 Enrollment ID: I20200727002110 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Kayla Klope |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1447685425 PECOS PAC ID: 9537585351 Enrollment ID: I20200811002558 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Laken Nicole Darnell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568076230 PECOS PAC ID: 1254758253 Enrollment ID: I20200903003083 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Janssen Shea Bailey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144813403 PECOS PAC ID: 1052726262 Enrollment ID: I20210222001854 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Shelby A Rollings-gough |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629677117 PECOS PAC ID: 0446667703 Enrollment ID: I20210402000238 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Megan Elizabeth Burcham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134706583 PECOS PAC ID: 6406265743 Enrollment ID: I20210517002399 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Tonya Ellington |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1992968945 PECOS PAC ID: 3476950692 Enrollment ID: I20210930000651 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Provider Name | Amy Christine Grogan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063162790 PECOS PAC ID: 8729465026 Enrollment ID: I20220505002243 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Imac Regeneration Center 2725 James Sanders Blvd, Suite A, Paducah, KY 42001-8401 Ph: (270) 554-5114 | Imac Regeneration Center 2725 James Sanders Blvd, Suite A, Paducah, KY 42001-8401 Ph: (270) 554-5114 |
News Archive
Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.
Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.
Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.
› Verified 3 days ago